2-amino-N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)acetamide hydrochloride, 95.0%, 250mg

2,4-Dibromoanisole>98.0%(GC)25g

2-Methyl-1,3,7-triazaspiro[4.5]dec-1-en-4-one hydrochloride, 95.0%, 100mg

4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)isoquinoline>98.0%(GC)5g

2-bromo-1-(3,3-difluorocyclobutyl)ethan-1-one, 95.0%, 100mg

N-hexylpyridinium bromide, 99%, 500g

1-methyl-1H-pyrazolo[4,3-c]pyridin-4-amine, 95.0%, 10g

Ethyl acetate, min. 99.5%, for synthesis, 2.5L, glass packaging

1,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 100mg

(3S,4R)-3-Fluoro-1-methylpiperidin-4-amine dihydrochloride, 98%, 250mg

(S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride, 95.0%, 250mg

methyl 5-((4-bromo-2-fluorophenyl)amino)-4-fluoro-1-methyl-1H-benzo[d]imidazole-6-carboxylate, 95%, 250mg

2-Chloro-5-methylpyrazine, 99.0%, 1g